Outcome | Population | Prevalence | Threshold effect (correlation coefficient) | P-value | AUSROC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | DOR (95% CI) |
---|---|---|---|---|---|---|---|---|
CMR3 [16, 20, 22,23,24, 26, 38, 42, 44, 53, 68,69,70,71,72,73,74,75,76,77,78, 83, 84] | 99,331 | 0.07 | − 0.053 | 0.811 | 0.91 (0.88, 0.93) | 0.84 (0.76, 0.90) | 0.84 (0.78, 0.88) | 28 (14, 54) |
46,448 | 0.11 | 0.271 | 0.481 | 0.85 (0.81, 0.88) | 0.83 (0.64, 0.93) | 0.77 (0.66, 0.84) | 16 (6, 45) | |
20,268 | 0.52 | − 0.212 | 0.788 | 0.75 (0.71, 0.79) | 0.55 (0.43, 0.66) | 0.84 (0.74, 0.91) | 7 (3, 15) | |
13,749 | 0.21 | 0.949 | < 0.001 | 0.59 (0.55, 0.63) | 0.54 (0.36, 0.70) | 0.62 (0.37, 0.82) | 2 (1, 3) | |
Elevated BP [20, 23, 42, 43, 46,47,48,49,50,51,52,53,54,55,56,57, 80,81,82,83,84,85] | 101,786 | 0.15 | 0.801 | < 0.001 | 0.69 (0.65,0.73) | 0.55 (0.45,0.64) | 0.74 (0.65,0.81) | 3 (3,4) |
73,092 | 0.14 | 0.859 | < 0.001 | 0.66 (0.62,0.70) | 0.54 (0.41,0.66) | 0.69 (0.60,0.77) | 3 (2,3) | |
12,599 | 0.08 | 0.860 | 0.026 | 0.70 (0.66, 0.74) | 0.58 (0.31, 0.80) | 0.71 (0.50, 0.86) | 3 (2, 5) | |
12,604 | 0.10 | 0.930 | 0.008 | 0.70 (0.66, 0.74) | 0.50 (0.24, 0.77) | 0.74 (0.58, 0.86) | 3 (2, 5) | |
148,115 | 0.18 | − 0.308 | 0.502 | 0.96 (0.94, 0.97) | 0.91 (0.84, 0.95) | 0.90 (0.86, 0.93) | 88 (40, 195) |